Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
EAG Laboratories
EAG Laboratories
Activities:
Analysis
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Analysis
EAG Laboratories and Attolight announce partnership
Partnership will aim to deliver advanced cathodoluminescence, photoluminescence and EBIC-scanning electron microscopy analytical services to the US
Regulatory
EAG Laboratories opens dedicated ICP-Mass spectroscopy laboratory
Investment addresses enhanced regulation of metals and impurities in pharmaceuticals
EAG Laboratories appoints Duane Huggett, Ph.D., as Senior Scientific Advisor 
for Its Environmental Testing Group
Expert in Environmental Risk Assessment, Toxicology and Pharmacology Joins Company
Subscribe now